Behavioral Neuroscience Laboratory, Department of Psychology, University of Nevada, Las Vegas, NV 89154, USA.
Behav Brain Res. 2012 Jul 15;233(1):35-44. doi: 10.1016/j.bbr.2012.04.049. Epub 2012 May 5.
Alterations in N-methyl-D-aspartate (NMDA) receptor function have been linked to numerous behavioral deficits and neurochemical alterations. Recent investigations have begun to explore the role of NMDA receptor function on principally inhibitory neurons and their role in network function. One of the prevailing models of schizophrenia proposes a reduction in NMDA receptor function on inhibitory interneurons and the resulting disinhibition may give rise to aspects of the disorder. Studies using NMDA receptor antagonists such as PCP and ketamine have induced schizophrenia-like behavioral deficits in animal model systems as well as changes in inhibitory circuits. The current study investigated whether the administration of a subanesthetic dose of ketamine (8 mg/kg subcutaneously), that disrupts sensorimotor gating, also produces impairments in a Pavlovian emotional learning and memory task. We utilized both standard delay and trace cued and contextual fear conditioning (CCF) paradigms to examine if ketamine produces differential effects when the task is more difficult and relies on connectivity between specific brain regions. Rats administered ketamine displayed no significant deficits in cued or contextual fear following the delay conditioning protocol. However, ketamine did produce a significant impairment in the more difficult trace conditioning protocol. Analyses of tissue from the hippocampus and amygdala indicated that the administration of ketamine produced an alteration in GABA receptor protein levels differentially depending on the task. These data indicate that 8 mg/kg of ketamine impairs learning in the more difficult emotional classical conditioning task and may be related to altered signaling in GABAergic systems.
N-甲基-D-天冬氨酸(NMDA)受体功能的改变与许多行为缺陷和神经化学改变有关。最近的研究开始探索 NMDA 受体功能对主要抑制性神经元的作用及其在网络功能中的作用。精神分裂症的一个流行模型提出,抑制性中间神经元上的 NMDA 受体功能降低,由此产生的去抑制可能导致该疾病的某些方面。使用 NMDA 受体拮抗剂如 PCP 和氯胺酮的研究在动物模型系统中诱导出类似精神分裂症的行为缺陷,以及抑制性回路的改变。本研究调查了亚麻醉剂量的氯胺酮(皮下 8mg/kg)是否会破坏感觉门控,也会导致帕夫洛夫式情绪学习和记忆任务的损伤。我们使用标准延迟和痕迹线索以及情境恐惧条件反射(CCF)范式来检查当任务更加困难且依赖于特定脑区之间的连接时,氯胺酮是否会产生不同的影响。给予氯胺酮的大鼠在延迟条件反射方案后,在线索或情境恐惧中没有显示出明显的缺陷。然而,氯胺酮确实在更困难的痕迹条件反射方案中产生了显著的损伤。对海马和杏仁核组织的分析表明,氯胺酮的给药导致 GABA 受体蛋白水平根据任务的不同而发生改变。这些数据表明,8mg/kg 的氯胺酮损害了更困难的情绪经典条件反射任务的学习,并且可能与 GABA 能系统中的信号改变有关。